> Currently, OWS is working with 11 drug manufacturing companies to produce 800 million doses of six different COVID-19 vaccines, five of which are in Phase III clinical trials. By prepurchasing and premanufacturing these vaccines prior to approval, the vaccine distribution plan can be activated and supplies delivered within 24 hours of any of the vaccines receiving FDA approval.
> Currently, OWS is working with 11 drug manufacturing companies to produce 800 million doses of six different COVID-19 vaccines, five of which are in Phase III clinical trials. By prepurchasing and premanufacturing these vaccines prior to approval, the vaccine distribution plan can be activated and supplies delivered within 24 hours of any of the vaccines receiving FDA approval.
https://college.acaai.org/updates-on-covid-19-vaccine-distri...